For Thousands, Psoriasis Is A Hidden Burden
The challenge that faces those working to help those living with psoriasis today is how to make those therapies more accessible to those who need it.
The challenge that faces those working to help those living with psoriasis today is how to make those therapies more accessible to those who need it.
Last year, the Ministry of Health released the findings of the Malaysia National Cancer Registry Report 2012–2016. The findings were bleak.
We should treat the individuals and communities affected by COVID-19 how we would wish ourselves to be treated, with empathy and compassion.
We need to increase early detection, expand effective treatment, provide care, and improve survival.
Vaccine hesitancy will result in people being unprotected and left behind.
Arguably, a CMCO at this point of time, could even increase people’s vulnerability to infection as they become more desperate, take more risks and are less able to afford to take precautions.
With shrinking national budgets, increasing deficits, demands for welfare assistance, and economies which are struggling to recover from month long lock-downs and harsh restrictive measures, investing in the unknown is a difficult decision to make.
The best chance of success for any country is to participate in an endeavour which diversifies and broadens access to a broad portfolio of possible vaccine candidates.
Proposals should not come from an angry or frustrated place, and must be evidence-based.
Now is not the time for countries to look inwards. The crisis will only be resolved, and economies will only recover, if countries are allowed to trade and collaborate freely with each other.